Caring Brands, Inc. (CABR) AI Stock Analysis
CABR AI stock analysis summary
AI ResearchCaring Brands, Inc. (CABR) is a wellness consumer products company offering over-the-counter and cosmetic products. In FY2025, the company generated $4,215 in revenue while recording a net income of -$6.3M. As of June 30, 2026, it held $1.8M in cash and short-term investments with a market capitalization of $12.6M.
- Market cap
- $12.6M
- Revenue (TTM)
- $1,159
- P/E
- —
- 1Y return
- -66.1% S&P 500 16.8%
- Avg. target
- —
Bull case
- The stock has gained 42.2% year-to-date and trades 6.8% above its 200-day moving average as of October 16, 2026.
- FY2025 revenue rose 806.5% to $4,215, accompanied by an improved gross margin of 55.6%.
- Balance sheet liquidity is supported by a current ratio of 4.96 and $1.8M in cash and short-term investments as of June 30, 2026.
Bear case
- Net losses widened to -$6.3M in FY2025, up from -$1.5M in FY2024.
- Free cash flow outflow worsened to -$1.7M in FY2025 from -$823,991 in FY2024.
- Over the trailing 1-year period, the stock fell 66.1%, trailing the S&P 500 return of 16.8%.
What Caring Brands does
Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema). The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women's sexual wellness products. Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.
Growth and profitability
Revenue was $20,421 in FY2023, fell 97.7% to $465 in FY2024, and rose 806.5% to $4,215 in FY2025, representing a 2-year revenue CAGR of -54.6%. Gross margin improved to 55.6% in FY2025 from -345.6% in FY2024. However, net losses widened from -$128,086 in FY2023 to -$1.5M in FY2024 and -$6.3M in FY2025, yielding an operating margin of -140807.2% in FY2025. Over the trailing twelve months ending June 30, 2026, revenue was $1,159, with an operating margin of -392263.6% and a quarterly revenue decline of 9.7% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, Caring Brands held $1.8M in cash and short-term investments against total assets of $1.9M and shareholders' equity of $1.5M. Its liquidity profile shows a current ratio of 4.96. For FY2025, operating cash flow was -$1.7M, resulting in free cash flow of -$1.7M, compared to free cash flow of -$823,991 in FY2024 and -$58,632 in FY2023.
Valuation and performance
Caring Brands trades at a price-to-book ratio of 4.0x, with a market capitalization of $12.6M and an enterprise value of $10.8M. By comparison, the median of its US-listed Healthcare peers trades at a price-to-sales multiple of 4.1x, a trailing P/E of 24.6x, and an EV-to-EBITDA ratio of 12.0x. CABR shares closed at $1.22 on October 16, 2026, down 66.1% over the past year versus a 16.8% return for the S&P 500 (SPY), though the stock is up 42.2% year-to-date and 6.8% above its 200-day average.
What analysts expect
There are no analyst rating counts, price targets, or revenue estimates reported for Caring Brands. The company's next earnings date is scheduled for November 13, 2026. For the trailing twelve months ending June 30, 2026, diluted earnings per share stood at -$0.78, following an EPS of -$0.05 in FY2024.
Key risks and what to watch
- Trailing twelve-month revenue totaled just $1,159, with latest quarterly revenue falling 9.7% year-over-year as of June 30, 2026.
- Operating cash burn reached -$1.7M in FY2025 compared to $1.8M in cash and short-term investments held as of June 30, 2026.
- The company operates with a workforce of 3 employees across several therapeutic and consumer categories.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this CABR AI stock analysis
This page is an AI-written research summary of Caring Brands, Inc. (CABR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: CABR income statement, CABR balance sheet, CABR key metrics, CABR chart. See the CABR stock overview for the latest quote and news.
CABR AI stock analysis FAQ
When is Caring Brands' next earnings date?
Caring Brands is scheduled to report earnings on November 13, 2026.
What is Caring Brands' cash position?
As of June 30, 2026, the company had $1.8M in cash and short-term investments, with total assets of $1.9M.
How has CABR performed over the past year?
Over the past 12 months, CABR fell 66.1%, compared to a 16.8% gain for the S&P 500. However, the stock is up 42.2% year-to-date as of October 16, 2026.
What products does Caring Brands provide?
The company offers Hair Enzyme Booster (JW-700), Photocil, CB-101 for eczema, NoStingz, and GoldN for Ebola diagnostics.